Followers | 605 |
Posts | 69362 |
Boards Moderated | 1 |
Alias Born | 01/09/2007 |
Monday, April 20, 2015 9:13:32 AM
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE
REQUESTED NOT TO SEND US A PROXY.
April 17, 2015
Notice of Written Consent in Lieu of Annual Meeting
To Shareholders of ERF Wireless, Inc.:
This Information Statement is furnished by the Board of Directors of ERF Wireless, Inc., a Nevada corporation (the “Company” or “ERF Wireless”) to holders of record at the close of business on March 20, 2015 (the “Record Date”) of the Company’s common stock, par value $0.001, pursuant to Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended ("Exchange Act").
The Company's Board of Directors and shareholders with a majority of the Company's voting power as of the Record Date have authorized the following actions:
1. Amendment to the Company’s Articles of Incorporation to increase the authorized common stock from 975,000,000 shares of common stock to 8,975,000,000 shares of common stock. The authorized amount of preferred stock will remain unchanged.
2. Reelection of H. Dean Cubley, Richard R. Royall, R. Greg Smith, Manny Carter, Bartus H. Batson to the Company’s Board of Directors for the ensuing year and until the next annual meeting of shareholders or until their successors are duly elected.
3. Ratification and approval of LBB & Associates Ltd., LLP as independent auditors of the Company.
These actions will not be effective until a date that is at least twenty days after the filing and mailing of this Information Statement. This Information Statement will be mailed on or about April 27, 2015, to the Company's stockholders of record.
The cost of preparing, assembling and mailing this Information Statement is being borne by the Company.
/s/ H. Dean Cubley
Dean Cubley
Chairman
April 17, 2015
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM